Total colectomy: indications and outcomes in colorectal pathology
DOI:
https://doi.org/10.18203/2320-6012.ijrms20261486Keywords:
Colorectal cancer, Total colectomy, Synchronous tumours, Mucinous adenocarcinoma, Ileorectal anastomosis, Surgical management, Oncologic surgery, Colon cancer, Multifocal diseaseAbstract
Colorectal cancer remains one of the leading causes of cancer-related morbidity and mortality worldwide. The presence of synchronous tumors poses a significant challenge in surgical management, often requiring more extensive resections to achieve adequate oncological control. Total colectomy is considered a viable option in selected patients with multifocal or extensive colonic disease, as it allows complete removal of the affected organ and reduces the risk of metachronous lesions. We present the case of a 62-year-old female patient with no significant family history, who presented with weight loss, anemia, and changes in bowel habits. Colonoscopy revealed two synchronous lesions located in the ascending colon and sigmoid colon. Histopathological analysis confirmed moderately differentiated mucinous adenocarcinoma in both sites. Imaging studies showed no evidence of distant metastasis. The patient underwent total colectomy with ileorectal anastomosis. The postoperative course was uneventful, with adequate recovery and no evidence of complications. Final pathology reported tumors staged as T3N0M0 and T2N0M0, with negative surgical margins and no lymph node involvement. At follow-up, the patient demonstrated good clinical evolution and satisfactory functional outcomes. This case highlights the importance of recognizing synchronous colorectal cancer and selecting an appropriate surgical strategy. Total colectomy provides an effective oncological approach in such cases, offering complete disease control and reducing the likelihood of future colonic malignancies.
References
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide. CA Cancer J Clin. 2018;68(6):394-424.
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7-30.
Benson AB, Venook AP, Al-Hawary MM, Cederquist L, Chen YJ, Ciombor KK, et al. NCCN guidelines insights: Colon cancer, version 2.2021. J Natl Compr Canc Netw. 2021;19(3):329-39.
Keum N, Giovannucci E. Global burden of colorectal cancer: Emerging trends, risk factors, and prevention strategies. Nat Rev Gastroenterol Hepatol. 2019;16(12):713-32.
Lynch HT, De la Chapelle A. Hereditary colorectal cancer. N Engl J Med. 2003;348(10):919-32.
Church JM. Prophylactic colectomy in patients with familial adenomatous polyposis. Ann Surg. 2019;269(4):606-11.
Vather R, Bissett I. Management of colorectal cancer: Current practice and future directions. World J Gastroenterol. 2013;19(38):6586-95.
Lee GH, Malietzis G, Askari A, Bernardo D, Clark SK, Faiz O. Is right hemicolectomy for cancer safe? A systematic review. Int J Colorectal Dis. 2015;30(12):1621-9.
Hohenberger W, Weber K, Matzel K, Papadopoulos T, Merkel S. Standardized surgery for colonic cancer. Lancet Oncol. 2009;10(6):597-605.
Bokey EL, Chapuis PH, Dent OF, Newland RC, Bissett IP, Smith RC, et al. Surgical technique and survival in colorectal cancer. Dis Colon Rectum. 1999;42(11):1370-6.
Stocchi L. Current indications and role of total colectomy. Clin Colon Rectal Surg. 2011;24(4):256-62.
Aalbers AG, Bemelman WA. Functional outcomes after total colectomy. Colorectal Dis. 2014;16(1):20-5.
Biondo S, Trenti L, Kreisler E, Espin-Basany E, Frago R, Golda T, et al. Outcomes of colectomy for colorectal cancer. World J Gastroenterol. 2012;18(24):3053-60.